Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares and Total Voting Rights

20 Jun 2019 16:14



Transaction in Own Shares and Total Voting Rights

Octopus AIM VCT 2 plc (“the Company”)

20 June 2019

Purchase of own securities and total voting rights

Octopus AIM VCT 2 plc announces that on 20 June 2019 the Company purchased for cancellation 161,371 Ordinary shares at a price of 74.4p per share.

Following this transaction, the issued share capital of the Company now consists of 110,338,630 Ordinary shares with a nominal value of 0.01p each, with voting rights.

For further enquiries, please contact:

Suzanna Waterhouse,Company Secretary 020 3142 4957


Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.